Indicator Explainer
Fibrinogen
A fibrillar protein present in blood plasma; it converts to fibrin during the process of blood clot formation.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C25736. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-18. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
Related Tests
Tests that measure or involve this indicator.
References
- NCI Thesaurus 26.09d — Fibrinogen (C25736)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C25736. NCI definition, reproduced without modification under CC BY 4.0.
- Effects of probiotic and synbiotic supplementation on fibrinogen and plasminogen activator inhibitor-1 concentrations: A Grading of Recommendations Assessment, Development and Evaluation-based systematic review and meta-analysis. — J Int Med Res, 2026-10-07 (PMID 42844594; literature)
- Fibrinogen activity and postpartum hemorrhage risk in women with congenital fibrinogen disorders: A multicenter real-world study. — Thromb Res, 2026-10-06 (PMID 42849188; literature)
- FTIR spectroscopy and chemometrics for monitoring fibrinogen-containing preparations during purification. — Biomol Biomed, 2026-10-06 (PMID 42841308; literature)
- Ferritin nanocages limit stable albumin and fibrinogen adsorption on gold nanoparticles under microfluidic flow. — Chem Commun (Camb), 2026-10-06 (PMID 42717732; literature)
- A human-cell recombinant prethrombin-2 platform producing thrombin with enhanced fibrinogen processing for in vitro applications. — Thromb Res, 2026-10-05 (PMID 42837787; literature)
- The role of fibrinogen concentrate in the reduction of allogeneic blood product requirements: a systematic review and meta-analysis. — Br J Anaesth, 2026-10-12 (PMID 42864190; literature)
- Concurrent fibrinogen Aα-chain amyloidosis and AA amyloidosis in a Humboldt penguin (Spheniscus humboldti). — Vet Res Commun, 2026-10-10 (PMID 42858211; literature)
- The FIBR-CMR score: a novel risk model integrating fibrinogen and cardiac magnetic resonance for major adverse events after STEMI. — Radiol Med, 2026-10-22 (PMID 42911529; literature)
- Enhancing the Structural Integrity of 3D Bioprinted Urethral Grafts for Clinical Applications using GelMA-Fibrinogen Bioinks Infused with Human Primary Cells. — Biofabrication, 2026-10-21 (PMID 42906614; literature)
- Systemic fibrinogen Aα-chain amyloidosis in 3 Japanese raccoon dogs. — J Vet Diagn Invest, 2026-10-27 (PMID 42937254; literature)
- Biochemical Characterization and Stability of a New Fibrinogen Concentrate (BT524) Manufactured Using an Innovative Virus Inactivation Step. — Drugs R D, 2026-10-25 (PMID 42928403; literature)